The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Milbemycin Oxime Market Research Report 2024
Synopsis
Used in dogs to treat fleas and clams, and to prevent heartworm disease/or treat the following types of intestinal nematode infections: roundworms (canis roundworms and Leonina toxoplasma), hookworms (canine hookworms) and whipworms (vulvar whipworms) ).
The global Milbemycin Oxime market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Milbemycin Oxime is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Milbemycin Oxime is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Milbemycin Oxime include Boehringer-Ingelheim, Virbac, Ceva, Krka, Elanco, Novartis and Purina, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Milbemycin Oxime, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Milbemycin Oxime.
Report Scope
The Milbemycin Oxime market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Milbemycin Oxime market comprehensively. Regional market sizes, concerning products by Dose, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Milbemycin Oxime manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Dose, by Application, and by regions.
Market Segmentation
By Company
Boehringer-Ingelheim
Virbac
Ceva
Krka
Elanco
Novartis
Purina
Segment by Dose
125mg/tablet
625mg/tablet
Segment by Application
Retail Pharmacy
Hospital Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Dose, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Milbemycin Oxime manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Milbemycin Oxime in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Dose, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Used in dogs to treat fleas and clams, and to prevent heartworm disease/or treat the following types of intestinal nematode infections: roundworms (canis roundworms and Leonina toxoplasma), hookworms (canine hookworms) and whipworms (vulvar whipworms) ).
The global Milbemycin Oxime market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Milbemycin Oxime is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Milbemycin Oxime is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Milbemycin Oxime include Boehringer-Ingelheim, Virbac, Ceva, Krka, Elanco, Novartis and Purina, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Milbemycin Oxime, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Milbemycin Oxime.
Report Scope
The Milbemycin Oxime market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Milbemycin Oxime market comprehensively. Regional market sizes, concerning products by Dose, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Milbemycin Oxime manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Dose, by Application, and by regions.
Market Segmentation
By Company
Boehringer-Ingelheim
Virbac
Ceva
Krka
Elanco
Novartis
Purina
Segment by Dose
125mg/tablet
625mg/tablet
Segment by Application
Retail Pharmacy
Hospital Pharmacy
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Dose, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Milbemycin Oxime manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Milbemycin Oxime in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Dose, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Milbemycin Oxime Market Overview
1.1 Product Overview and Scope of Milbemycin Oxime
1.2 Milbemycin Oxime Segment by Dose
1.2.1 Global Milbemycin Oxime Market Value Comparison by Dose (2024-2030)
1.2.2 125mg/tablet
1.2.3 625mg/tablet
1.3 Milbemycin Oxime Segment by Application
1.3.1 Global Milbemycin Oxime Market Value by Application: (2024-2030)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Others
1.4 Global Milbemycin Oxime Market Size Estimates and Forecasts
1.4.1 Global Milbemycin Oxime Revenue 2019-2030
1.4.2 Global Milbemycin Oxime Sales 2019-2030
1.4.3 Global Milbemycin Oxime Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Milbemycin Oxime Market Competition by Manufacturers
2.1 Global Milbemycin Oxime Sales Market Share by Manufacturers (2019-2024)
2.2 Global Milbemycin Oxime Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Milbemycin Oxime Average Price by Manufacturers (2019-2024)
2.4 Global Milbemycin Oxime Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Milbemycin Oxime, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Milbemycin Oxime, Product Type & Application
2.7 Milbemycin Oxime Market Competitive Situation and Trends
2.7.1 Milbemycin Oxime Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Milbemycin Oxime Players Market Share by Revenue
2.7.3 Global Milbemycin Oxime Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Milbemycin Oxime Retrospective Market Scenario by Region
3.1 Global Milbemycin Oxime Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Milbemycin Oxime Global Milbemycin Oxime Sales by Region: 2019-2030
3.2.1 Global Milbemycin Oxime Sales by Region: 2019-2024
3.2.2 Global Milbemycin Oxime Sales by Region: 2025-2030
3.3 Global Milbemycin Oxime Global Milbemycin Oxime Revenue by Region: 2019-2030
3.3.1 Global Milbemycin Oxime Revenue by Region: 2019-2024
3.3.2 Global Milbemycin Oxime Revenue by Region: 2025-2030
3.4 North America Milbemycin Oxime Market Facts & Figures by Country
3.4.1 North America Milbemycin Oxime Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Milbemycin Oxime Sales by Country (2019-2030)
3.4.3 North America Milbemycin Oxime Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Milbemycin Oxime Market Facts & Figures by Country
3.5.1 Europe Milbemycin Oxime Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Milbemycin Oxime Sales by Country (2019-2030)
3.5.3 Europe Milbemycin Oxime Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Milbemycin Oxime Market Facts & Figures by Country
3.6.1 Asia Pacific Milbemycin Oxime Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Milbemycin Oxime Sales by Country (2019-2030)
3.6.3 Asia Pacific Milbemycin Oxime Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Milbemycin Oxime Market Facts & Figures by Country
3.7.1 Latin America Milbemycin Oxime Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Milbemycin Oxime Sales by Country (2019-2030)
3.7.3 Latin America Milbemycin Oxime Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Milbemycin Oxime Market Facts & Figures by Country
3.8.1 Middle East and Africa Milbemycin Oxime Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Milbemycin Oxime Sales by Country (2019-2030)
3.8.3 Middle East and Africa Milbemycin Oxime Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Dose
4.1 Global Milbemycin Oxime Sales by Dose (2019-2030)
4.1.1 Global Milbemycin Oxime Sales by Dose (2019-2024)
4.1.2 Global Milbemycin Oxime Sales by Dose (2025-2030)
4.1.3 Global Milbemycin Oxime Sales Market Share by Dose (2019-2030)
4.2 Global Milbemycin Oxime Revenue by Dose (2019-2030)
4.2.1 Global Milbemycin Oxime Revenue by Dose (2019-2024)
4.2.2 Global Milbemycin Oxime Revenue by Dose (2025-2030)
4.2.3 Global Milbemycin Oxime Revenue Market Share by Dose (2019-2030)
4.3 Global Milbemycin Oxime Price by Dose (2019-2030)
5 Segment by Application
5.1 Global Milbemycin Oxime Sales by Application (2019-2030)
5.1.1 Global Milbemycin Oxime Sales by Application (2019-2024)
5.1.2 Global Milbemycin Oxime Sales by Application (2025-2030)
5.1.3 Global Milbemycin Oxime Sales Market Share by Application (2019-2030)
5.2 Global Milbemycin Oxime Revenue by Application (2019-2030)
5.2.1 Global Milbemycin Oxime Revenue by Application (2019-2024)
5.2.2 Global Milbemycin Oxime Revenue by Application (2025-2030)
5.2.3 Global Milbemycin Oxime Revenue Market Share by Application (2019-2030)
5.3 Global Milbemycin Oxime Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer-Ingelheim
6.1.1 Boehringer-Ingelheim Corporation Information
6.1.2 Boehringer-Ingelheim Description and Business Overview
6.1.3 Boehringer-Ingelheim Milbemycin Oxime Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer-Ingelheim Milbemycin Oxime Product Portfolio
6.1.5 Boehringer-Ingelheim Recent Developments/Updates
6.2 Virbac
6.2.1 Virbac Corporation Information
6.2.2 Virbac Description and Business Overview
6.2.3 Virbac Milbemycin Oxime Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Virbac Milbemycin Oxime Product Portfolio
6.2.5 Virbac Recent Developments/Updates
6.3 Ceva
6.3.1 Ceva Corporation Information
6.3.2 Ceva Description and Business Overview
6.3.3 Ceva Milbemycin Oxime Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ceva Milbemycin Oxime Product Portfolio
6.3.5 Ceva Recent Developments/Updates
6.4 Krka
6.4.1 Krka Corporation Information
6.4.2 Krka Description and Business Overview
6.4.3 Krka Milbemycin Oxime Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Krka Milbemycin Oxime Product Portfolio
6.4.5 Krka Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Milbemycin Oxime Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Elanco Milbemycin Oxime Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Milbemycin Oxime Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Milbemycin Oxime Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Purina
6.6.1 Purina Corporation Information
6.6.2 Purina Description and Business Overview
6.6.3 Purina Milbemycin Oxime Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Purina Milbemycin Oxime Product Portfolio
6.7.5 Purina Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Milbemycin Oxime Industry Chain Analysis
7.2 Milbemycin Oxime Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Milbemycin Oxime Production Mode & Process
7.4 Milbemycin Oxime Sales and Marketing
7.4.1 Milbemycin Oxime Sales Channels
7.4.2 Milbemycin Oxime Distributors
7.5 Milbemycin Oxime Customers
8 Milbemycin Oxime Market Dynamics
8.1 Milbemycin Oxime Industry Trends
8.2 Milbemycin Oxime Market Drivers
8.3 Milbemycin Oxime Market Challenges
8.4 Milbemycin Oxime Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Milbemycin Oxime Market Value Comparison by Dose (2024-2030) & (US$ Million)
Table 2. Global Milbemycin Oxime Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Milbemycin Oxime Market Competitive Situation by Manufacturers in 2023
Table 4. Global Milbemycin Oxime Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Milbemycin Oxime Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Milbemycin Oxime Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Milbemycin Oxime Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Milbemycin Oxime Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Milbemycin Oxime, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Milbemycin Oxime, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Milbemycin Oxime, Product Type & Application
Table 12. Global Key Manufacturers of Milbemycin Oxime, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Milbemycin Oxime by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Milbemycin Oxime as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Milbemycin Oxime Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Milbemycin Oxime Sales by Region (2019-2024) & (K Units)
Table 18. Global Milbemycin Oxime Sales Market Share by Region (2019-2024)
Table 19. Global Milbemycin Oxime Sales by Region (2025-2030) & (K Units)
Table 20. Global Milbemycin Oxime Sales Market Share by Region (2025-2030)
Table 21. Global Milbemycin Oxime Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Milbemycin Oxime Revenue Market Share by Region (2019-2024)
Table 23. Global Milbemycin Oxime Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Milbemycin Oxime Revenue Market Share by Region (2025-2030)
Table 25. North America Milbemycin Oxime Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Milbemycin Oxime Sales by Country (2019-2024) & (K Units)
Table 27. North America Milbemycin Oxime Sales by Country (2025-2030) & (K Units)
Table 28. North America Milbemycin Oxime Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Milbemycin Oxime Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Milbemycin Oxime Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Milbemycin Oxime Sales by Country (2019-2024) & (K Units)
Table 32. Europe Milbemycin Oxime Sales by Country (2025-2030) & (K Units)
Table 33. Europe Milbemycin Oxime Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Milbemycin Oxime Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Milbemycin Oxime Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Milbemycin Oxime Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Milbemycin Oxime Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Milbemycin Oxime Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Milbemycin Oxime Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Milbemycin Oxime Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Milbemycin Oxime Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Milbemycin Oxime Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Milbemycin Oxime Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Milbemycin Oxime Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Milbemycin Oxime Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Milbemycin Oxime Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Milbemycin Oxime Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Milbemycin Oxime Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Milbemycin Oxime Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Milbemycin Oxime Sales (K Units) by Dose (2019-2024)
Table 51. Global Milbemycin Oxime Sales (K Units) by Dose (2025-2030)
Table 52. Global Milbemycin Oxime Sales Market Share by Dose (2019-2024)
Table 53. Global Milbemycin Oxime Sales Market Share by Dose (2025-2030)
Table 54. Global Milbemycin Oxime Revenue (US$ Million) by Dose (2019-2024)
Table 55. Global Milbemycin Oxime Revenue (US$ Million) by Dose (2025-2030)
Table 56. Global Milbemycin Oxime Revenue Market Share by Dose (2019-2024)
Table 57. Global Milbemycin Oxime Revenue Market Share by Dose (2025-2030)
Table 58. Global Milbemycin Oxime Price (US$/Unit) by Dose (2019-2024)
Table 59. Global Milbemycin Oxime Price (US$/Unit) by Dose (2025-2030)
Table 60. Global Milbemycin Oxime Sales (K Units) by Application (2019-2024)
Table 61. Global Milbemycin Oxime Sales (K Units) by Application (2025-2030)
Table 62. Global Milbemycin Oxime Sales Market Share by Application (2019-2024)
Table 63. Global Milbemycin Oxime Sales Market Share by Application (2025-2030)
Table 64. Global Milbemycin Oxime Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Milbemycin Oxime Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Milbemycin Oxime Revenue Market Share by Application (2019-2024)
Table 67. Global Milbemycin Oxime Revenue Market Share by Application (2025-2030)
Table 68. Global Milbemycin Oxime Price (US$/Unit) by Application (2019-2024)
Table 69. Global Milbemycin Oxime Price (US$/Unit) by Application (2025-2030)
Table 70. Boehringer-Ingelheim Corporation Information
Table 71. Boehringer-Ingelheim Description and Business Overview
Table 72. Boehringer-Ingelheim Milbemycin Oxime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Boehringer-Ingelheim Milbemycin Oxime Product
Table 74. Boehringer-Ingelheim Recent Developments/Updates
Table 75. Virbac Corporation Information
Table 76. Virbac Description and Business Overview
Table 77. Virbac Milbemycin Oxime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Virbac Milbemycin Oxime Product
Table 79. Virbac Recent Developments/Updates
Table 80. Ceva Corporation Information
Table 81. Ceva Description and Business Overview
Table 82. Ceva Milbemycin Oxime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Ceva Milbemycin Oxime Product
Table 84. Ceva Recent Developments/Updates
Table 85. Krka Corporation Information
Table 86. Krka Description and Business Overview
Table 87. Krka Milbemycin Oxime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Krka Milbemycin Oxime Product
Table 89. Krka Recent Developments/Updates
Table 90. Elanco Corporation Information
Table 91. Elanco Description and Business Overview
Table 92. Elanco Milbemycin Oxime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Elanco Milbemycin Oxime Product
Table 94. Elanco Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Milbemycin Oxime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Novartis Milbemycin Oxime Product
Table 99. Novartis Recent Developments/Updates
Table 100. Purina Corporation Information
Table 101. Purina Description and Business Overview
Table 102. Purina Milbemycin Oxime Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Purina Milbemycin Oxime Product
Table 104. Purina Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Milbemycin Oxime Distributors List
Table 108. Milbemycin Oxime Customers List
Table 109. Milbemycin Oxime Market Trends
Table 110. Milbemycin Oxime Market Drivers
Table 111. Milbemycin Oxime Market Challenges
Table 112. Milbemycin Oxime Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Milbemycin Oxime
Figure 2. Global Milbemycin Oxime Market Value Comparison by Dose (2024-2030) & (US$ Million)
Figure 3. Global Milbemycin Oxime Market Share by Dose in 2023 & 2030
Figure 4. 125mg/tablet Product Picture
Figure 5. 625mg/tablet Product Picture
Figure 6. Global Milbemycin Oxime Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Milbemycin Oxime Market Share by Application in 2023 & 2030
Figure 8. Retail Pharmacy
Figure 9. Hospital Pharmacy
Figure 10. Others
Figure 11. Global Milbemycin Oxime Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Milbemycin Oxime Market Size (2019-2030) & (US$ Million)
Figure 13. Global Milbemycin Oxime Sales (2019-2030) & (K Units)
Figure 14. Global Milbemycin Oxime Average Price (US$/Unit) & (2019-2030)
Figure 15. Milbemycin Oxime Report Years Considered
Figure 16. Milbemycin Oxime Sales Share by Manufacturers in 2023
Figure 17. Global Milbemycin Oxime Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Milbemycin Oxime Players: Market Share by Revenue in 2023
Figure 19. Milbemycin Oxime Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Milbemycin Oxime Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Milbemycin Oxime Sales Market Share by Country (2019-2030)
Figure 22. North America Milbemycin Oxime Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Milbemycin Oxime Sales Market Share by Country (2019-2030)
Figure 26. Europe Milbemycin Oxime Revenue Market Share by Country (2019-2030)
Figure 27. Germany Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Milbemycin Oxime Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Milbemycin Oxime Revenue Market Share by Region (2019-2030)
Figure 34. China Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Milbemycin Oxime Sales Market Share by Country (2019-2030)
Figure 45. Latin America Milbemycin Oxime Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Milbemycin Oxime Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Milbemycin Oxime Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Milbemycin Oxime Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Milbemycin Oxime by Dose (2019-2030)
Figure 55. Global Revenue Market Share of Milbemycin Oxime by Dose (2019-2030)
Figure 56. Global Milbemycin Oxime Price (US$/Unit) by Dose (2019-2030)
Figure 57. Global Sales Market Share of Milbemycin Oxime by Application (2019-2030)
Figure 58. Global Revenue Market Share of Milbemycin Oxime by Application (2019-2030)
Figure 59. Global Milbemycin Oxime Price (US$/Unit) by Application (2019-2030)
Figure 60. Milbemycin Oxime Value Chain
Figure 61. Milbemycin Oxime Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
